Metraipolis › archive › dc_761ff87ea310

Promoter Hypermethylation-Driven NPHS2 Silencing Promotes Immune Escape and Sunitinib Resistance in Clear Cell Renal Cell Carcinoma — Europe PMC PMID:42769428

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42769428
DOI: 10.32604/or.2026.080228
License (as archived): solo-consultazione
Archived: 2026-10-10T02:19:51.230Z
SHA-256 of the archived text: 872f4124184c3f379275be52581bde1d410103d58aa47ff73fb8bb2f61b85c10
Stable URL of this page: https://metraipolis.com/documento/dc_761ff87ea310

How to cite

Promoter Hypermethylation-Driven NPHS2 Silencing Promotes Immune Escape and Sunitinib Resistance in Clear Cell Renal Cell Carcinoma — Europe PMC PMID:42769428 — Europe PMC (en), https://europepmc.org/article/MED/42769428 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_761ff87ea310 (Metraipolis archive dc_761ff87ea310, sha256 872f4124184c3f379275be52581bde1d410103d58aa47ff73fb8bb2f61b85c10)

BibTeX

@misc{dc761ff87ea310,
  title = {Promoter Hypermethylation-Driven NPHS2 Silencing Promotes Immune Escape and Sunitinib Resistance in Clear Cell Renal Cell Carcinoma — Europe PMC PMID:42769428},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42769428},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_761ff87ea310; sha256 872f4124184c3f379275be52581bde1d410103d58aa47ff73fb8bb2f61b85c10},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42769428. Agents can read the archived copy with the MCP tool read_document.